Jefferies downgrades Biocon to 'underperform', sees 11% downside; here's why : vimarsana.com

Jefferies has downgraded the pharma stock Biocon to 'underperform' from 'hold'. However, Jefferies has maintained its target price of ₹250 for the stock, implying an 11 percent downside from its current market price of ₹281.50.

Related Keywords

Malaysia , Bangalore , Karnataka , India , Biocon Biologics , Biocon , Economic Times , Biocon Stock , Biocon Share Price , Biocon Shares , Biocon Stock Price , Jefferies On Biocon , Jefferies Downgrades Biocon , Biocon Target Price , Biocon Downgrade , Pharma , Markets , Stocks , Stock Markets , Jefferies , Market News , Stock News , Business News , Investing , Biocon News ,